COMMUNIQUÉS West-GlobeNewswire

CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale
02/06/2026
CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale Dijon, France 02 juin 2026 (17h45 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ) , la société [...]
GENFIT Annual General Meeting of June 15, 2026 - Shareholders' letter
02/06/2026
Dear Shareholders, We are pleased to send you, in the attached document, GENFIT’s Shareholders’ Letter published ahead of our Annual General Meeting to be held on June 15, 2026. This letter outlines the key elements [...]
Adverse Effects of COVID Vaccine on Musculoskeletal Conditions Need Research, according to the Journal of American Physicians and Surgeons
02/06/2026
TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) -- The contentious issue of musculoskeletal adverse effects of COVID-19 vaccines arises in the context of the collapse of public trust in academic expertise, writes Jane M. [...]
GENFIT : Assemblée Générale Mixte du 15 juin 2026 - Lettre aux actionnaires
02/06/2026
Chers Actionnaires, Nous avons le plaisir de vous adresser, en pièce jointe, la Lettre aux actionnaires de GENFIT publiée à l’approche de notre Assemblée Générale Mixte du 15 juin 2026. Cette lettre revient sur les [...]
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
02/06/2026
$8.5 million upfront with up to approximately $15.1 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond [...]
Update on the Carbios - Wankai project in China
02/06/2026
Clermont-Ferrand (France), 2 June 2026 (05:45 pm CEST). Carbios (Euronext Growth Paris: ALCRB) provides an update on the progress of its strategic partnership with Wankai New Materials (“ Wankai ”) in the field of PET [...]
AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share
02/06/2026
PRESS RELEASE STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE Paris, June 2 nd , 2026, 6pm CET AB Science SA (Euronext - [...]
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
02/06/2026
Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology [...]
NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization
02/06/2026
Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- [...]
Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting
02/06/2026
- The trial achieved its primary goal of selecting the efficacious and safe dose of onvansertib + standard-of-care (SoC) regimen for the registrational program - - 30 mg onvansertib + FOLFIRI/bevacizumab arm showed a [...]
Oraticx Expands Oral Probiotics Lineup for Daily Oral Care and Oral Microbiome Wellness
02/06/2026
New product range introduces targeted probiotic oral care solutions for everyday wellness routines Oraticx Logo LOS ANGELES, June 02, 2026 (GLOBE NEWSWIRE) -- Oraticx, a wellness brand focused on oral microbiome balance [...]
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
02/06/2026
“Relocating the Root” is a scoping literature review on the mental health needs of people directly impacted by the criminal legal system Publishing this literature review launches a project that builds on nearly four [...]
Myriad Genetics Names Raj Jampa as New Chief Technology Officer
02/06/2026
SALT LAKE CITY, June 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces today the appointment of Raj Jampa as chief technology [...]
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
02/06/2026
Promising Phase 1 data for LB2501, a potential first ‑ in ‑ class CD19/CD20 dual ‑ targeting in vivo CAR-T therapy, as an off-the-shelf, single-infusion treatment for B ‑ cell malignancies An ORR of 100% (6/6) was [...]
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
02/06/2026
Defense-industry veteran brings experience developing imaging, sensing, and intelligence systems for aerospace, defense, and homeland security NETANYA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American [...]
OncoBag launches innovative handbag for post-mastectomy women
02/06/2026
Polish Femtech pioneer begins pre-sales of revolutionary OncoBag Wroclaw, Poland, June 02, 2026 (GLOBE NEWSWIRE) -- OncoBag, a pioneering Polish femtech and wellness company, has announced the pre-sale of its [...]
Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally
02/06/2026
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Evosep and Molecular You today announced a strategic collaboration to advance standardized, high-throughput multi-omic testing for personalized biomarker profiling. The [...]
USOSM Supports OMS Foundation Through 2026 Matching-Gift Incentive
02/06/2026
IRVING, Texas, June 02, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) is proud to announce its continued support of the OMS Foundation with a gift-match incentive for the Foundation’s mid-year [...]
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
02/06/2026
CHICAGO, June 02, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, [...]

Pages